Women who undergo breast-conserving surgery for ductal carcinoma in situ (DCIS) often do not receive long-term surveillance mammography, according to a study published online May 11 in the Journal of Clinical Oncology.
Women who undergo breast-conserving surgery for ductal carcinoma in situ (DCIS) often do not receive long-term surveillance mammography, according to a study published online May 11 in the Journal of Clinical Oncology.
Larissa Nekhlyudov, MD, from Harvard Medical School in Boston, and colleagues reviewed the medical records of 3,037 women who were treated with breast-conserving surgery for DCIS.
After observation for a median of 4.8 years, the researchers found that the percentage of women undergoing surveillance mammography fell from 79% after 1 year to 61% after 10 years. Among women observed for at least 5 years, the likelihood of receiving surveillance mammography was higher for women in their 60s (odds ratio, 1.72), women receiving menopausal hormone therapy at diagnosis (odds ratio, 1.26), and women receiving adjuvant radiation (odds ratio, 1.28) and radiation with tamoxifen (odds ratio, 1.61). Obese women were less likely to undergo mammography (odds ratio, 0.70).
"In summary, we found that surveillance mammography after breast-conserving surgery for DCIS among insured women often did not occur yearly and that surveillance declined over time,"
Nekhlyudov and colleagues conclude. "Because DCIS is considered to be a precursor to invasive breast cancer, it is particularly important for women to receive surveillance for recurrences of DCIS and/or newly diagnosed invasive breast cancer."Nekhlyudov L, Habel LA, Achacoso NS, et al. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009 May 11. [Epub ahead of print]. Doi:10.1200/JCO.2008.18.5876.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More